Clinical Publications

Insights from
your peers

NovoSorb® BTM is cleared for a variety of challenging indications. Surgeons from multiple specialties have conducted research on BTM to evaluate efficacy and outcomes.


Complex Wounds

  • 2022 Frost SR, Deodhar A & Offer GJ ‘A novel use for the biodegradable temporizing matrix.’ Eur J Plast Surg (2022).

  • 2022 Wu SS, Wells M, Ascha M, Gatherwright J & Chepla K Performance of biodegradable temporizing matrix vs collagen-chondroitin silicone bilayer dermal regeneration substitutes in soft tissue wound healing: a retrospective analysis.’ Wounds;34(4):106–115


Necrotizing fasciitis

  • 2019 Sreedharan S, Morrison E, Cleland H, Ricketts S & Bruscino-Raiola F ‘Biodegradable temporizing matrix for necrotizing soft tissue infections: a case report.’ Australian Journal of Plastic Surgery; 2(1): 106-109

  • 2019 Wagstaff MJD, Salna IM, Caplash Y & Greenwood JE ‘Biodegradable Temporizing Matrix (BTM) for the reconstruction of defects following serial debridement for necrotizing fasciitis: A case series.’ Burns Open; 3:12-30



  • 2015a Wagstaff MJD, Schmitt B, Coghlan P, Finkemeyer JP, Caplash Y & Greenwood JE ‘A biodegradable polyurethane dermal matrix in reconstruction of free flap donor site: A pilot study.’ Eplasty; 15: 102-18

  • 2014 Dearman BL, Li A & Greenwood JE ‘Optimization of a polyurethane dermal matrix and experience with a polymer-based cultured composite skin.’ Journal of Burn Care & Research; 35(5):437-48